{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T00:56:28Z","timestamp":1781139388395,"version":"3.54.1"},"reference-count":30,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,24]],"date-time":"2026-04-24T00:00:00Z","timestamp":1776988800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100007270","name":"University of Michigan","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007270","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100017003","name":"Peking University Health Science Center","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100017003","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Autoimmunity"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.jaut.2026.103563","type":"journal-article","created":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T03:56:49Z","timestamp":1777262209000},"page":"103563","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Endothelial cell-derived plasminogen activator inhibitor-1 potentiates thrombosis in antiphospholipid syndrome"],"prefix":"10.1016","volume":"161","author":[{"given":"Yuzhou","family":"Gan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenying","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chao","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Srilakshmi","family":"Yalavarthi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Warnock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaitlyn","family":"Sabb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cyrus","family":"Sarosh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jordan K.","family":"Schaefer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ajay","family":"Tambralli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacqueline A.","family":"Madison","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cory D.","family":"Emal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pei-Suen","family":"Tsou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Zuo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel A.","family":"Lawrence","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0995-9771","authenticated-orcid":false,"given":"Jason S.","family":"Knight","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaut.2026.103563_bib1","article-title":"Antiphospholipid syndrome: advances in diagnosis, pathogenesis, and management","volume":"380","author":"Knight","year":"2023","journal-title":"BMJ"},{"issue":"21","key":"10.1016\/j.jaut.2026.103563_bib2","doi-asserted-by":"crossref","first-page":"2010","DOI":"10.1056\/NEJMra1705454","article-title":"Diagnosis and management of the antiphospholipid syndrome","volume":"378","author":"Garcia","year":"2018","journal-title":"N. Engl. J. Med."},{"issue":"3","key":"10.1016\/j.jaut.2026.103563_bib3","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1007\/s00281-022-00916-w","article-title":"Mechanisms of immunothrombosis and vasculopathy in antiphospholipid syndrome","volume":"44","author":"Knight","year":"2022","journal-title":"Semin. Immunopathol."},{"issue":"5","key":"10.1016\/j.jaut.2026.103563_bib4","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1055\/s-0041-1725098","article-title":"Impaired fibrinolysis in the antiphospholipid syndrome","volume":"47","author":"Antovic","year":"2021","journal-title":"Semin. Thromb. Hemost."},{"issue":"3","key":"10.1016\/j.jaut.2026.103563_bib5","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1055\/s-0042-1758791","article-title":"Past, present, and future perspectives of plasminogen activator inhibitor 1 (PAI-1)","volume":"49","author":"Morrow","year":"2023","journal-title":"Semin. Thromb. Hemost."},{"issue":"3","key":"10.1016\/j.jaut.2026.103563_bib6","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1007\/s00393-019-00689-y","article-title":"Association between plasminogen activator inhibitor-1 (PAI-1) 4G\/5G polymorphism and circulating PAI-1 level in systemic lupus erythematosus and rheumatoid arthritis","volume":"79","author":"Bae","year":"2020","journal-title":"A meta-analysis. Z Rheumatol."},{"issue":"5","key":"10.1016\/j.jaut.2026.103563_bib7","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1097\/MBC.0000000000000080","article-title":"Plasma thrombin-activatable fibrinolysis inhibitor levels in children and adolescents with type 1 diabetes mellitus: possible relation to diabetic microvascular complications","volume":"25","author":"Sherif","year":"2014","journal-title":"Blood Coagul. Fibrinolysis"},{"issue":"12","key":"10.1016\/j.jaut.2026.103563_bib8","doi-asserted-by":"crossref","first-page":"3589","DOI":"10.1016\/j.jtha.2023.09.007","article-title":"Fibrinogenolysis and fibrinolysis in vaccine-induced immune thrombocytopenia and thrombosis","volume":"21","author":"Simpson","year":"2023","journal-title":"J. Thromb. Haemostasis"},{"issue":"3","key":"10.1016\/j.jaut.2026.103563_bib9","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20030619","article-title":"The role of fibrinolytic regulators in vascular dysfunction of systemic sclerosis","volume":"20","author":"Kanno","year":"2019","journal-title":"Int. J. Mol. Sci."},{"issue":"9","key":"10.1016\/j.jaut.2026.103563_bib10","doi-asserted-by":"crossref","first-page":"2331","DOI":"10.1007\/s00296-013-2717-0","article-title":"Elevated plasminogen activator inhibitor type-1 (PAI-1) as contributing factor in pathogenesis of hypercoagulable state in antiphospholipid syndrome","volume":"33","author":"Singh","year":"2013","journal-title":"Rheumatol. Int."},{"key":"10.1016\/j.jaut.2026.103563_bib11","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCULATIONAHA.125.073552","article-title":"Microvascular endothelial cells license APS vasculopathy through YAP1- and CCN2-Mediated signaling","author":"Shi","year":"2025","journal-title":"Circulation"},{"issue":"2","key":"10.1016\/j.jaut.2026.103563_bib12","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1111\/j.1538-7836.2006.01753.x","article-title":"International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS)","volume":"4","author":"Miyakis","year":"2006","journal-title":"J. Thromb. Haemostasis"},{"issue":"1","key":"10.1016\/j.jaut.2026.103563_bib13","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1038\/s41598-020-80010-z","article-title":"Plasma tissue plasminogen activator and plasminogen activator inhibitor-1 in hospitalized COVID-19 patients","volume":"11","author":"Zuo","year":"2021","journal-title":"Sci. Rep."},{"issue":"11","key":"10.1016\/j.jaut.2026.103563_bib14","doi-asserted-by":"crossref","first-page":"2990","DOI":"10.1002\/art.39247","article-title":"Release of neutrophil extracellular traps by neutrophils stimulated with antiphospholipid antibodies: a newly identified mechanism of thrombosis in the antiphospholipid syndrome","volume":"67","author":"Yalavarthi","year":"2015","journal-title":"Arthritis Rheumatol."},{"key":"10.1016\/j.jaut.2026.103563_bib15","doi-asserted-by":"crossref","DOI":"10.1016\/j.clim.2023.109714","article-title":"Interaction of the antiphospholipid syndrome autoantigen beta-2 glycoprotein I with DNA and neutrophil extracellular traps","volume":"255","author":"Kme\u0165ov\u00e1","year":"2023","journal-title":"Clin. Immunol."},{"issue":"5","key":"10.1016\/j.jaut.2026.103563_bib16","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1074\/jbc.RA118.004885","article-title":"Dual-reporter high-throughput screen for small-molecule in vivo inhibitors of plasminogen activator inhibitor type-1 yields a clinical lead candidate","volume":"294","author":"Reinke","year":"2019","journal-title":"J. Biol. Chem."},{"issue":"15","key":"10.1016\/j.jaut.2026.103563_bib17","doi-asserted-by":"crossref","DOI":"10.1172\/JCI169893","article-title":"Neutrophil glucose flux as a therapeutic target in antiphospholipid syndrome","volume":"134","author":"Tambralli","year":"2024","journal-title":"J. Clin. Investig."},{"issue":"8","key":"10.1016\/j.jaut.2026.103563_bib18","doi-asserted-by":"crossref","first-page":"1446","DOI":"10.1161\/ATVBAHA.117.309451","article-title":"Plasminogen activator Inhibitor-1 is a marker and a mediator of senescence","volume":"37","author":"Vaughan","year":"2017","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"12","key":"10.1016\/j.jaut.2026.103563_bib19","doi-asserted-by":"crossref","first-page":"684","DOI":"10.3858\/emm.2011.43.12.079","article-title":"Inhibition of NF-\u03baB prevents high glucose-induced proliferation and plasminogen activator inhibitor-1 expression in vascular smooth muscle cells","volume":"43","author":"Jeong","year":"2011","journal-title":"Exp. Mol. Med."},{"issue":"1","key":"10.1016\/j.jaut.2026.103563_bib20","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1007\/s11926-009-0075-4","article-title":"Impaired fibrinolysis in the antiphospholipid syndrome","volume":"12","author":"Krone","year":"2010","journal-title":"Curr. Rheumatol. Rep."},{"issue":"Suppl 1","key":"10.1016\/j.jaut.2026.103563_bib21","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1111\/ijlh.14268","article-title":"Noncriteria antiphospholipid antibodies in antiphospholipid syndrome","volume":"46","author":"Devreese","year":"2024","journal-title":"Int. J. Lab. Hematol."},{"issue":"SI","key":"10.1016\/j.jaut.2026.103563_bib22","doi-asserted-by":"crossref","first-page":"SI64","DOI":"10.1093\/rheumatology\/kead632","article-title":"Viewpoint: the value of non-criteria antiphospholipid antibodies","volume":"63","author":"de Laat","year":"2024","journal-title":"Rheumatology"},{"issue":"1","key":"10.1016\/j.jaut.2026.103563_bib23","first-page":"31","article-title":"Prothrombotic effect of Anti-beta-2 Glycoprotein-1 antibodies on the expression of tissue factor, Thrombomodulin, and plasminogen activator Inhibitor-1 in endothelial cells","volume":"47","author":"Rikarni","year":"2015","journal-title":"Acta Med. Indones."},{"issue":"3","key":"10.1016\/j.jaut.2026.103563_bib24","doi-asserted-by":"crossref","first-page":"891","DOI":"10.3390\/jcm12030891","article-title":"Advances in the pathophysiology of thrombosis in antiphospholipid syndrome: molecular mechanisms and signaling through lipid rafts","volume":"12","author":"Capozzi","year":"2023","journal-title":"J. Clin. Med."},{"issue":"12","key":"10.1016\/j.jaut.2026.103563_bib25","doi-asserted-by":"crossref","first-page":"3135","DOI":"10.3390\/biomedicines11123135","article-title":"Role of lipid rafts on LRP8 signaling triggered by Anti-\u03b22-GPI antibodies in endothelial cells","volume":"11","author":"Riitano","year":"2023","journal-title":"Biomedicines"},{"key":"10.1016\/j.jaut.2026.103563_bib26","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.thromres.2022.04.001","article-title":"NLRP3 inflammasome contributes to endotoxin-induced coagulation","volume":"214","author":"Shi","year":"2022","journal-title":"Thromb. Res."},{"issue":"8","key":"10.1016\/j.jaut.2026.103563_bib27","doi-asserted-by":"crossref","first-page":"4796","DOI":"10.1093\/rheumatology\/keaf204","article-title":"Anti-\u03b22glycoprotein I-induced neutrophil extracellular traps cause endothelial activation","volume":"64","author":"Mancuso","year":"2025","journal-title":"Rheumatology"},{"issue":"5","key":"10.1016\/j.jaut.2026.103563_bib28","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1007\/s12975-022-00992-y","article-title":"Compartmentalized actions of the plasminogen activator inhibitors, PAI-1 and Nsp, in ischemic stroke","volume":"13","author":"Torrente","year":"2022","journal-title":"Transl Stroke Res"},{"issue":"6","key":"10.1016\/j.jaut.2026.103563_bib29","first-page":"1192","article-title":"Gene polymorphisms of tissue plasminogen activator and plasminogen activator inhibitor-1 in patients with antiphospholipid antibodies","volume":"29","author":"Yasuda","year":"2002","journal-title":"J. Rheumatol."},{"issue":"10","key":"10.1016\/j.jaut.2026.103563_bib30","doi-asserted-by":"crossref","first-page":"2349","DOI":"10.1002\/1529-0131(200010)43:10<2349::AID-ANR24>3.0.CO;2-J","article-title":"The 4G\/5G polymorphism of the type 1 plasminogen activator inhibitor gene and thrombosis in patients with antiphospholipid syndrome","volume":"43","author":"T\u00e0ssies","year":"2000","journal-title":"Arthritis Rheum."}],"container-title":["Journal of Autoimmunity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0896841126000417?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0896841126000417?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T23:57:48Z","timestamp":1781135868000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0896841126000417"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":30,"alternative-id":["S0896841126000417"],"URL":"https:\/\/doi.org\/10.1016\/j.jaut.2026.103563","relation":{},"ISSN":["0896-8411"],"issn-type":[{"value":"0896-8411","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Endothelial cell-derived plasminogen activator inhibitor-1 potentiates thrombosis in antiphospholipid syndrome","name":"articletitle","label":"Article Title"},{"value":"Journal of Autoimmunity","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaut.2026.103563","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"103563"}}